Drawing for AUTONOMY

USPTO serial 97720895

AUTONOMY

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
CHISOLM,KEVON
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with AUTONOMY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michele H. Bowman

Michele H. Bowman Abbott Laboratories100 Abbott Park RoadAbbott Park, IL 60064United States

Goods and services

ClassDescriptionStatusFirst use
005Insulin injectors sold filled with insulinACTIVE—
009Downloadable mobile application used in conjunction with blood glucose meter and insulin delivery devices for management of diabetes including, capturing, measuring, monitoring, and tracking blood glucose, predicting blood glucose levels, providing recommendations for insulin dosage requirements, and controlling medicament delivery in the field of diabetes management; downloadable computer software for use by healthcare providers and patients with diabetes for use in the collection, display, transmission, management, monitoring, tracking, and sharing of health and medical information for management of diabetesACTIVE—
010Medical devices for use in managing diabetes, namely, insulin injection devices capable of capturing, measuring, tracking, and monitoring insulin dosage amounts; insulin injectors sold empty; medical test kits for managing diabetes consisting of blood glucose meters, pen cap with embedded software for collecting time and dosage data, pen cap charging device, single-use pen needles for injecting insulin, continuous glucose monitoring sensor for monitoring glucose levels, test strips, lancing device, lancets, alcohol pads, and carrying caseACTIVE—
035Subscription mail order services in the field of diabetes supplies delivered to the homeACTIVE—
042Software as a service (SAAS) services featuring software for facilitating the remote access and interoperability of blood glucose meters and mobile applications for data management, monitoring, tracking, sharing, analyzing and viewing of health and medical information for the management of diabetesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jan 19, 2026MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 19, 2026ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 15, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 2, 2025EX3GSOU EXTENSION 3 GRANTED—
Jun 2, 2025EXT3SOU EXTENSION 3 FILED—
Jun 2, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 3, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 17, 2024EX2GSOU EXTENSION 2 GRANTED—
Dec 17, 2024EXT2SOU EXTENSION 2 FILED—
Dec 17, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 13, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 3, 2024EX1GSOU EXTENSION 1 GRANTED—
Jun 3, 2024EXT1SOU EXTENSION 1 FILED—
Jun 3, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 14, 2024EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
May 14, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 14, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 14, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 14, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 14, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Dec 19, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 24, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 24, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 4, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 20, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 19, 2023DOCKASSIGNED TO EXAMINER—
Jan 12, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 20, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance